COYA THERAPEUTICS INC (COYA) Fundamental Analysis & Valuation

NASDAQ:COYA • US22407B1089

4.79 USD
+0.05 (+1.05%)
Last: Mar 6, 2026, 08:09 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This COYA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Taking everything into account, COYA scores 3 out of 10 in our fundamental rating. COYA was compared to 520 industry peers in the Biotechnology industry. While COYA has a great health rating, there are worries on its profitability. COYA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. COYA Profitability Analysis

1.1 Basic Checks

  • COYA had negative earnings in the past year.
  • COYA had a negative operating cash flow in the past year.
  • COYA had negative earnings in each of the past 5 years.
  • COYA had a negative operating cash flow in each of the past 5 years.
COYA Yearly Net Income VS EBIT VS OCF VS FCFCOYA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • COYA has a Return On Assets of -57.53%. This is comparable to the rest of the industry: COYA outperforms 43.46% of its industry peers.
  • With a Return On Equity value of -67.56%, COYA perfoms like the industry average, outperforming 56.15% of the companies in the same industry.
Industry RankSector Rank
ROA -57.53%
ROE -67.56%
ROIC N/A
ROA(3y)-66.21%
ROA(5y)-61.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COYA Yearly ROA, ROE, ROICCOYA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

  • COYA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
COYA Yearly Profit, Operating, Gross MarginsCOYA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. COYA Health Analysis

2.1 Basic Checks

  • COYA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for COYA has been increased compared to 1 year ago.
  • There is no outstanding debt for COYA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
COYA Yearly Shares OutstandingCOYA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
COYA Yearly Total Debt VS Total AssetsCOYA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • An Altman-Z score of 10.68 indicates that COYA is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 10.68, COYA belongs to the top of the industry, outperforming 82.50% of the companies in the same industry.
  • COYA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.68
ROIC/WACCN/A
WACC8.77%
COYA Yearly LT Debt VS Equity VS FCFCOYA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • COYA has a Current Ratio of 8.73. This indicates that COYA is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of COYA (8.73) is better than 76.35% of its industry peers.
  • COYA has a Quick Ratio of 8.73. This indicates that COYA is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of COYA (8.73) is better than 76.35% of its industry peers.
Industry RankSector Rank
Current Ratio 8.73
Quick Ratio 8.73
COYA Yearly Current Assets VS Current LiabilitesCOYA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. COYA Growth Analysis

3.1 Past

  • The earnings per share for COYA have decreased strongly by -111.54% in the last year.
  • The Revenue for COYA has decreased by -58.26% in the past year. This is quite bad
EPS 1Y (TTM)-111.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-58.26%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, COYA will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.57% on average per year.
  • The Revenue is expected to grow by 29.27% on average over the next years. This is a very strong growth
EPS Next Y-25.59%
EPS Next 2Y-25.05%
EPS Next 3Y-7.05%
EPS Next 5Y10.57%
Revenue Next Year64.5%
Revenue Next 2Y-59.75%
Revenue Next 3Y34.01%
Revenue Next 5Y29.27%

3.3 Evolution

COYA Yearly Revenue VS EstimatesCOYA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
COYA Yearly EPS VS EstimatesCOYA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

0

4. COYA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for COYA. In the last year negative earnings were reported.
  • Also next year COYA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COYA Price Earnings VS Forward Price EarningsCOYA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COYA Per share dataCOYA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

  • COYA's earnings are expected to decrease with -7.05% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-25.05%
EPS Next 3Y-7.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. COYA Dividend Analysis

5.1 Amount

  • COYA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

COYA Fundamentals: All Metrics, Ratios and Statistics

COYA THERAPEUTICS INC

NASDAQ:COYA (3/6/2026, 8:09:33 PM)

4.79

+0.05 (+1.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)03-24
Inst Owners18.8%
Inst Owner Change62.13%
Ins Owners1.2%
Ins Owner Change0%
Market Cap112.33M
Revenue(TTM)3.99M
Net Income(TTM)-18.43M
Analysts83.08
Price Target16.39 (242.17%)
Short Float %3.91%
Short Ratio3.71
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.77%
Min EPS beat(2)10.16%
Max EPS beat(2)53.37%
EPS beat(4)3
Avg EPS beat(4)-5.14%
Min EPS beat(4)-121.22%
Max EPS beat(4)53.37%
EPS beat(8)5
Avg EPS beat(8)-2.98%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-42.52%
Min Revenue beat(2)-79.47%
Max Revenue beat(2)-5.56%
Revenue beat(4)0
Avg Revenue beat(4)-68.14%
Min Revenue beat(4)-97.13%
Max Revenue beat(4)-5.56%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)2.05%
EPS NQ rev (3m)8.28%
EPS NY rev (1m)0.59%
EPS NY rev (3m)21.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)20.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 28.17
P/FCF N/A
P/OCF N/A
P/B 4.12
P/tB 4.12
EV/EBITDA N/A
EPS(TTM)-1.1
EYN/A
EPS(NY)-1.52
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS0.17
BVpS1.16
TBVpS1.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -57.53%
ROE -67.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-66.21%
ROA(5y)-61.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.73
Quick Ratio 8.73
Altman-Z 10.68
F-Score2
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-111.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y-25.59%
EPS Next 2Y-25.05%
EPS Next 3Y-7.05%
EPS Next 5Y10.57%
Revenue 1Y (TTM)-58.26%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year64.5%
Revenue Next 2Y-59.75%
Revenue Next 3Y34.01%
Revenue Next 5Y29.27%
EBIT growth 1Y-80.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.7%
OCF growth 3YN/A
OCF growth 5YN/A

COYA THERAPEUTICS INC / COYA FAQ

What is the fundamental rating for COYA stock?

ChartMill assigns a fundamental rating of 3 / 10 to COYA.


Can you provide the valuation status for COYA THERAPEUTICS INC?

ChartMill assigns a valuation rating of 0 / 10 to COYA THERAPEUTICS INC (COYA). This can be considered as Overvalued.


What is the profitability of COYA stock?

COYA THERAPEUTICS INC (COYA) has a profitability rating of 1 / 10.


How financially healthy is COYA THERAPEUTICS INC?

The financial health rating of COYA THERAPEUTICS INC (COYA) is 8 / 10.